Pura Vida Investments, LLC's Form 4/A amendment
AmendedInsight Molecular Diagnostics Inc. (IMDX) · filed Jun 28, 2022
- Accession no.
- 0001209191-22-039690
- Filed
- Jun 28, 2022, 7:46 PM ET
- Trade date
- Apr 14, 2022
- Filing delay
- 75 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Apr 18, 2022
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market purchases total $250.3K. It was filed 75 days after the trade.
This amendment replaces 0001829126-22-009190 (filed Apr 29, 2022).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pura Vida Investments, LLCCIK 0001590144 | 10% Owner |
| Kamen EfremCIK 0001789193 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 14, 2022 | Common Stock | PPurchaseAcquired | +30,790 | $1.23 | +$37,779.33 | 7,381,237 | Indirect | |
| Apr 14, 2022 | Common Stock | PPurchaseAcquired | +92,370 | $1.26 | +$116,386.2 | 7,473,607 | Indirect | |
| Apr 14, 2022 | Common Stock | PPurchaseAcquired | +19,210 | $1.23 | +$23,570.67 | 8,475,033 | Indirect | |
| Apr 14, 2022 | Common Stock | PPurchaseAcquired | +57,630 | $1.26 | +$72,613.8 | 8,532,663 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.